TrialHelicobacter

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents.

Anja Šterbenc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.